Department of Radiology, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Int J Nanomedicine. 2019 Oct 24;14:8499-8507. doi: 10.2147/IJN.S219749. eCollection 2019.
BACKGROUND: Beyond magnetic resonance imaging (MRI), which has been widely used clinically, molecular MRI (mMRI) can further provide qualitative and quantitative information at the cellular and molecular levels. However, the diagnostic accuracy may not be satisfactory via single-contrast mMRI due to some interferences in vivo. T/T dual-contrast MRI using the same contrast agent (CA) could significantly improve the detection accuracy. Therefore, in this study, we fabricated poly(ethylene glycol) (PEG)-coated, manganese-doped iron oxide nanocomposites (Mn-IONPs@PEG) as T/T dual-contrast CA, and evaluated its feasibility of T/T dual-contrast MRI in vitro and in vivo. METHODS: Mn-IONPs were prepared by the thermal decomposition of iron-eruciate and manganese-oleate complexes and were coated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy[polyethylene glycol]-2000) (DSPE-PEG 2000). The physicochemical properties and cytotoxicity of the Mn-IONPs were fully characterized, followed by MRI in vitro and in vivo. RESULTS: Ultrasmall 3 nm-sized nanoparticles were successfully prepared and were identified using transmission electron microscopy (TEM), high-resolution TEM, and X-ray diffraction. After coating with DSPE-PEG, the Mn-IONPs@PEG displayed excellent hydrophilicity and good biocompatibility. Due to the manganese-doping and PEG coating, the Mn-IONPs@PEG showed good relaxivity in vitro. Especially, the Mn-IONPs@PEG coated with DSPE-PEG following a mass ratio to Mn-IONPs of 1:20 showed harmonious longitudinal relaxivity ( = 7.1 mMs) and transversal relaxivity ( = 120.9 mMs), making it a better candidate for T/T dual-contrast mMRI. After administrated via a caudal vein, the Mn-IONPs@PEG can induce significant enhancement in both T-weighted and T-weighted MR images and the time at 10 mins after injection was regarded as a suitable time for imaging because both the T and T enhancement were optimum at that time. CONCLUSION: The obtained Mn-IONPs@PEG exhibited good and and was a reasonable candidate for T/T dual-contrast mMRI.
背景:除了广泛应用于临床的磁共振成像(MRI)外,分子 MRI(mMRI)还可以在细胞和分子水平上提供定性和定量信息。然而,由于体内的一些干扰,单一对比 mMRI 的诊断准确性可能并不理想。使用相同造影剂(CA)的 T/T 双对比 MRI 可以显著提高检测准确性。因此,在这项研究中,我们制备了聚乙二醇(PEG)包覆的锰掺杂氧化铁纳米复合材料(Mn-IONPs@PEG)作为 T/T 双对比 CA,并评估了其在体外和体内 T/T 双对比 MRI 的可行性。 方法:Mn-IONPs 通过铁草酸盐和油酸锰配合物的热分解制备,并通过 1,2-二硬脂酰基-sn-甘油-3-磷酸乙醇胺-N-(甲氧基[聚乙二醇]-2000)(DSPE-PEG 2000)进行包覆。对 Mn-IONPs 的理化性质和细胞毒性进行了充分的表征,随后进行了体外和体内 MRI 研究。 结果:通过透射电子显微镜(TEM)、高分辨率 TEM 和 X 射线衍射成功制备了超小 3nm 尺寸的纳米粒子。经 DSPE-PEG 包覆后,Mn-IONPs@PEG 表现出优异的亲水性和良好的生物相容性。由于锰掺杂和 PEG 包覆,Mn-IONPs@PEG 在体外具有良好的弛豫率。特别是,DSPE-PEG 与 Mn-IONPs 的质量比为 1:20 时,Mn-IONPs@PEG 表现出良好的纵向弛豫率( = 7.1 mMs)和横向弛豫率( = 120.9 mMs),使其成为 T/T 双对比 mMRI 的较好候选物。尾静脉给药后,Mn-IONPs@PEG 可引起 T 加权和 T 加权 MR 图像的显著增强,注射后 10 分钟是成像的合适时间,因为此时 T 和 T 增强均达到最佳。 结论:所获得的 Mn-IONPs@PEG 表现出良好的弛豫性能,是 T/T 双对比 mMRI 的合理候选物。
Colloids Surf B Biointerfaces. 2015-4-29
Mater Sci Eng C Mater Biol Appl. 2014-4-28
Mol Imaging. 2023
Nanoscale Adv. 2022-8-25
Front Oncol. 2022-6-2
Molecules. 2021-6-5
J Nanobiotechnology. 2021-5-3
Int J Nanomedicine. 2018-8-10
Chem Soc Rev. 2017-11-27
Chem Rev. 2017-1-3